Trexquant Investment’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-384,074
Closed -$3M 1648
2024
Q2
$3M Sell
384,074
-106,668
-22% -$790K 0.05% 586
2024
Q1
$3.48M Buy
490,742
+334,889
+215% +$2.22M 0.07% 436
2023
Q4
$1.04M Buy
155,853
+124,468
+397% +$701K 0.02% 811
2023
Q3
$177K Buy
+31,385
New +$209K ﹤0.01% 1357
2023
Q2
Sell
-187,624
Closed -$1.17M 1559
2023
Q1
$1.17M Sell
187,624
-101,012
-35% -$563K 0.03% 667
2022
Q4
$1.35M Buy
+288,636
New +$1.42M 0.04% 539
2022
Q1
Sell
-44,591
Closed -$1.46M 1487
2021
Q4
$1.46M Buy
44,591
+37,764
+553% +$1.52M 0.09% 282
2021
Q3
$280K Sell
6,827
-26,006
-79% -$944K 0.02% 768
2021
Q2
$1.18M Buy
+32,833
New +$1.21M 0.1% 271

Other funds holding GDRX

Trexquant Investment's GDRX Position: Q3 2024 in Review

Trexquant Investment sold out of GoodRx Holdings (GDRX) in Q3 2024, closing a stake of 384,074 shares — an estimated $3M sold.

Trexquant Investment first reported a position in GDRX in Q2 2021 and held it in 9 quarters. The position peaked at $3.48M in Q1 2024. 168 funds tracked by Wall St. Rank hold GDRX as of Q3 2024.

  • Trexquant Investment reported no remaining GoodRx Holdings position as of Q3 2024 after selling out during the quarter.
  • Trexquant Investment sold 384,074 GoodRx Holdings shares in Q3 2024, an estimated $3M.
  • Trexquant Investment first reported a position in GoodRx Holdings in Q2 2021 and held it in 9 quarters.
  • Trexquant Investment's GoodRx Holdings position peaked at $3.48M in Q1 2024.
  • 168 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2024.

Based on Trexquant Investment's 13F filing for Q3 2024, filed 12 Nov 2024.